help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majalahti-Palviainen, T.
Right arrow Articles by Vuolteenaho, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majalahti-Palviainen, T.
Right arrow Articles by Vuolteenaho, O.
Right arrowPubmed/NCBI databases
*Nucleotide*Protein
*Substance via MeSH
Endocrinology Vol. 141, No. 2 731-740
Copyright © 2000 by The Endocrine Society

ARTICLES

Gene Structure of a New Cardiac Peptide Hormone: A Model for Heart-Specific Gene Expression1

Theresa Majalahti-Palviainen, Minna Hirvinen, Virpi Tervonen, Mika Ilves, Heikki Ruskoaho and Olli Vuolteenaho

Departments of Physiology and Pharmacology and Toxicology (H.R.), Biocenter Oulu, University of Oulu, FIN-90220 Oulu, Finland

Address all correspondence and requests for reprints to: Dr. Olli Vuolteenaho, Department of Physiology, University of Oulu, Kajaanintie 52A, FIN-90220 Oulu, Finland. E-mail: olli.vuolteenaho{at}oulu.fi

Volume excess and mechanical load lead to the induction of the endocrine activity of the heart. The increased production and secretion of A- and B-type natriuretic peptides (ANP and BNP), in turn, unload the heart due to their physiological effects. To find out the mechanisms of cardiac-specific expression and sensitivity to mechanical stimuli of the natriuretic peptide genes, we have used salmon (Salmo salar) as our model organism, because osmoregulating fish have a particularly well developed defense mechanism against volume excess. We have previously cloned a complementary DNA from salmon heart encoding a novel vasorelaxant cardiac hormone, salmon cardiac peptide (sCP). Its production is restricted to the heart, and its release is very sensitive to mechanical load. We have now cloned the gene encoding sCP. The structure of the gene suggests that sCP may represent an ancestral form of the mammalian natriuretic peptides. Remarkably, despite the large phylogenetic distance, the sCP promoter is as effective as mammalian ANP promoters in cultured neonatal rat atrial cardiomyocytes. Therefore, structural and functional comparisons of the promoters of sCP and ANP provide an excellent means of identifying the elements and transcription factors required for atrial-specific gene expression and the regulation of the endocrine function of the heart. Isolation of the protein product of sCP gene from salmon atrium demonstrated that the storage form of sCP is the prohormone of 126 amino acids. The final processing of the prohormone appears to take place during exocytosis of the secretory granules, as the released and circulating form is the biologically active 29-amino acid sCP.




This article has been cited by other articles:


Home page
 CirculationHome page
T. O. Peltonen, P. Taskinen, Y. Soini, J. Rysa, J. Ronkainen, P. Ohtonen, J. Satta, T. Juvonen, H. Ruskoaho, and H. Leskinen
Distinct Downregulation of C-Type Natriuretic Peptide System in Human Aortic Valve Stenosis
Circulation, September 11, 2007; 116(11): 1283 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A.-M. Moilanen, J. Hakkola, M. H. Vaarala, S. Kauppila, P. Hirvikoski, J. T. Vuoristo, R. J. Edwards, and T. K. Paavonen
Characterization of androgen-regulated expression of CYP3A5 in human prostate
Carcinogenesis, May 1, 2007; 28(5): 916 - 921.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
O. Tenhunen, Y. Soini, M. Ilves, J. Rysa, J. Tuukkanen, R. Serpi, H. Pennanen, H. Ruskoaho, and H. Leskinen
p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms
FASEB J, September 1, 2006; 20(11): 1907 - 1909.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Vierimaa, J. Ronkainen, H. Ruskoaho, and O. Vuolteenaho
Synergistic activation of salmon cardiac function by endothelin and beta-adrenergic stimulation
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1360 - H1370.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
G. Foldes, S. Vajda, Z. Lako-Futo, B. Sarman, R. Skoumal, M. Ilves, R. deChatel, I. Karadi, M. Toth, H. Ruskoaho, et al.
Distinct modulation of angiotensin II-induced early left ventricular hypertrophic gene programming by dietary fat type
J. Lipid Res., June 1, 2006; 47(6): 1219 - 1226.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
K. Savolainen, T. J. Kotti, W. Schmitz, T. I. Savolainen, R. T. Sormunen, M. Ilves, S. J. Vainio, E. Conzelmann, and J. K. Hiltunen
A mouse model for {alpha}-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids
Hum. Mol. Genet., May 1, 2004; 13(9): 955 - 965.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
P. Tavi, S. Pikkarainen, J. Ronkainen, P. Niemela, M. Ilves, M. Weckstrom, O. Vuolteenaho, J. Bruton, H. Westerblad, and H. Ruskoaho
Pacing-induced calcineurin activation controls cardiac Ca2+ signalling and gene expression
J. Physiol., January 15, 2004; 554(2): 309 - 320.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
Z. Lako-Futo, I. Szokodi, B. Sarman, G. Foldes, H. Tokola, M. Ilves, H. Leskinen, O. Vuolteenaho, R. Skoumal, R. deChatel, et al.
Evidence for a Functional Role of Angiotensin II Type 2 Receptor in the Cardiac Hypertrophic Process In Vivo in the Rat Heart
Circulation, November 11, 2003; 108(19): 2414 - 2422.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Backlund, E. Palojoki, A. Saraste, T. Gronholm, A. Eriksson, P. Lakkisto, O. Vuolteenaho, M. S Nieminen, L.-M. Voipio-Pulkki, M. Laine, et al.
Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction
Cardiovasc Res, March 1, 2003; 57(3): 727 - 737.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. Piuhola, I. Szokodi, P. Kinnunen, M. Ilves, R. deChatel, O. Vuolteenaho, and H. Ruskoaho
Endothelin-1 Contributes to the Frank-Starling Response in Hypertrophic Rat Hearts
Hypertension, January 1, 2003; 41(1): 93 - 98.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Heikkila, H. Peltoketo, J. Leppaluoto, M. Ilves, O. Vuolteenaho, and S. Vainio
Wnt-4 Deficiency Alters Mouse Adrenal Cortex Function, Reducing Aldosterone Production
Endocrinology, November 1, 2002; 143(11): 4358 - 4365.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Szokodi, P. Tavi, G. Foldes, S. Voutilainen-Myllyla, M. Ilves, H. Tokola, S. Pikkarainen, J. Piuhola, J. Rysa, M. Toth, et al.
Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility
Circ. Res., September 6, 2002; 91(5): 434 - 440.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
V. Tervonen, H. Ruskoaho, T. Lecklin, M. Ilves, and O. Vuolteenaho
Salmon cardiac natriuretic peptide is a volume-regulating hormone
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E353 - E361.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A.-P. Kvist, A. Latvanlehto, M. Sund, L. Eklund, T. Vaisanen, P. Hagg, R. Sormunen, J. Komulainen, R. Fassler, and T. Pihlajaniemi
Lack of Cytosolic and Transmembrane Domains of Type XIII Collagen Results in Progressive Myopathy
Am. J. Pathol., October 1, 2001; 159(4): 1581 - 1592.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Piuhola, A. Hammes, K. Schuh, L. Neyses, O. Vuolteenaho, and H. Ruskoaho
Overexpression of sarcolemmal calcium pump attenuates induction of cardiac gene expression in response to ET-1
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R699 - R705.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fässler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al.
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
PNAS, January 23, 2001; (2001) 31444798.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fassler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al.
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
PNAS, January 30, 2001; 98(3): 1194 - 1199.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Vierimaa, M. Hirvinen, V. Tervonen, O. Arjamaa, H. Ruskoaho, and O. Vuolteenaho
Pronatriuretic peptide is a sensitive marker of the endocrine function of teleost heart
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E843 - E850.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society